Geode Capital Management’s Epirus Biopharmaceuticals EPRS Stock Holding History
Bought
Maintained
Sold
Other funds holding EPRS
Geode Capital Management's EPRS Position: Q3 2016 in Review
Geode Capital Management sold out of Epirus Biopharmaceuticals (EPRS) in Q3 2016, closing a stake of 82,821 shares — an estimated $37K sold.
Geode Capital Management first reported a position in EPRS in Q3 2014 and held it in 8 quarters. The position peaked at $574K in Q1 2015. 3 funds tracked by Wall St. Rank hold EPRS as of Q3 2016.
- Geode Capital Management reported no remaining Epirus Biopharmaceuticals position as of Q3 2016 after selling out during the quarter.
- Geode Capital Management sold 82,821 Epirus Biopharmaceuticals shares in Q3 2016, an estimated $37K.
- Geode Capital Management first reported a position in Epirus Biopharmaceuticals in Q3 2014 and held it in 8 quarters.
- Geode Capital Management's Epirus Biopharmaceuticals position peaked at $574K in Q1 2015.
- 3 funds tracked by Wall St. Rank held Epirus Biopharmaceuticals as of Q3 2016.
Based on Geode Capital Management's 13F filing for Q3 2016, filed 10 Nov 2016.